PubMed Health⌕ Search

Biomedical subjects

R Muller-Runkel

Publications and source records attributed to R Muller-Runkel.

At least 19 recordsLinked to original sources

Measurement of dosimetric parameters for the Alpha-Omega high-dose-rate Iridium-192 source.

Thermoluminescent (TLD) measurements of dose-rate constant, anisotropy function, and radial dose function are reported for the Alpha-Omega high dose rate (HDR) Iridium-192 ((192)Ir) source, which has been available since 1998 for use in the MicroSelectron HDR afterloader manufactured by the Nucletron Corporation. Measurement results are compared with published or available Monte Carlo calculations for both sources. They are found in good agreement, and, within experimental accuracy, no difference is seen in the dosimetric parameters of both sources.

Iridium Radioisotopes↗

Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.

The purpose of this investigation was to examine changes in pretreatment prostate-specific antigen (PSA), stage, and grade over the past decade as a function of race and geographic region. A multiinstitutional database representing 6,790 patients (1,417 African-American, 5,373 white) diagnosed with nonmetastatic prostate cancer between 1988 and 1997 was constructed. PSA, stage, and grade data were tabulated by calendar year and region, and time trend analyses based on race and region were performed. There was an overall decline of PSA of 0.8%/year, which was significant (P = 0.0001), with a faster rate of decline in African-Americans (1.9%/year) than for whites (0.6%/year). The odds ratio (OR) for a stage shift was 1.09, which was significant (P < 0.0001), and this shift was greater in whites. The OR for an overall grade shift was 1.15, which was significant (P < 0.0001). Although grade and PSA trends were similar for the different regions, there were significant regional differences in stage trends. The implications are that the face of prostate cancer has changed over the past decade; i.e., the distributions of stage, grade, and PSA (the most important prognosticators) have changed. In addition, the countenances of that face are different for whites and African-Americans. For African-Americans, this is good news: the stage, grade, and PSA distributions are more favorable now than before. For whites, the trends are more complex and more dependent on region. These findings should be used for future clinical and health-policy decisions in the screening and treatment of prostate cancer.

Black People↗

Determination of the tissue attenuation factor along two major axes of a high dose rate (HDR) 192Ir source.

Quantitative information on photon scattering around brachytherapy sources is needed to develop dose calculation formalisms capable of predicting dosimetric parameters with minimal empiricism. Photon absorption and scatter around brachytherapy sources can be characterized using the tissue attenuation factor, defined as the ratio of dose in water to water kerma in free space. In this study, the tissue attenuation factor along two major axes of a high dose rate (HDR) 192Ir source was determined by TLD measurements and MCNP Monte Carlo calculations. A calculational method is also suggested to derive the tissue attenuation factor along the longitudinal source axis from the factor along the transverse axis, using published anisotropy data as input. TLD and Monte Carlo results agreed with each other for both source axes within the statistical uncertainty (approximately +/- 5%) of Monte Carlo calculations. Comparison with published data, available only for the transverse source axis, also showed good agreement within +/- 5%. The shape and magnitude of the tissue attenuation factor are found to be remarkably different between the two axes. The tissue attenuation factor reaches a maximum value of about 1.4 at 8 cm from the source along the longitudinal source axis, while a maximum value of about 1.04 occurs at 3-4 cm from the source along the transverse axis. The calculated tissue attenuation factor along the longitudinal source axis generally reproduced the TLD and Monte Carlo results within +/- 5% at most radial distances.

Anisotropy↗

Validity of the interval method for the determination of the anisotropy factor of high dose rate 192Ir sources.

PURPOSE: This study investigates the validity of the interval method to determine the anisotropy factors of high dose rate (HDR) 192Ir sources. METHODS AND MATERIALS: A calculation method, which is one of the various numerical implementations of the Sievert integral and known as the interval method, is applied to determine the anisotropy factors of a HDR 192Ir source. Calculated results from r = 1 cm to 10 cm are compared to published data. RESULTS: The comparison shows that the error resulting from the interval method increases from 1.3 to 28.1% as the radial distance increases from r = 1 cm to 10 cm and is significantly smaller than that previously reported. CONCLUSIONS: The interval method might be considered as a method that provides a very rough estimate of the anisotropy of HDR 192Ir sources whenever no conclusive anisotropy data is available.

Brachytherapy↗

Evaluation of a commercial three-dimensional electron pencil beam algorithm.

Results from beta testing of a commercially available three-dimensional electron pencil beam algorithm (CMS FOCUS, Computerized Medical Systems, Inc. St. Louis, MO) are reported. Straight on beams were evaluated at normal and extended distances, and obliquely incident beams at angles up to 40 degrees. Shaped electron fields with small circular cutouts, and narrow elongated, centered and offcentered, rectangular field shapes were investigated. Slab inhomogeneities were studied for lung and bone equivalent material, and isodose distributions for small inhomogeneities of these materials were compared with film and TLD measurements. All tests reported here were performed with electrons 6, 12, and 20 MeV from a Cl-1800 accelerator.

Algorithms↗

Effect of anisotropy corrections on the dynamic dose calculations in high dose rate (HDR) brachytherapy.

An analytic formalism utilizing a convolution technique is presented for the incorporation of anisotropy corrections into the dynamic (or transit) dose calculations in high dose rate (HDR) brachytherapy. A simple numerical implementation of the suggested formalism is also presented. Two calculational examples are provided in order to show some effects of anisotropy corrections on the dynamic dose calculations. Based on the results from these examples and published literature, the absence of anisotropy corrections in the dynamic dose calculations could result in a dosimetric error up to the order of 0.1 Gy during the full course of HDR brachytherapy treatments depending on fractionation and geometrical arrangement. Therefore, the incorporation of anisotropy corrections into dynamic dose calculations could eliminate this kind of error in HDR brachytherapy.

Algorithms↗

Anisotropy measurements of a high dose rate Ir-192 source in air and in polystyrene.

Anisotropy measurements in air and in polystyrene were performed for a Nucletron microSelectron 10 Ci Ir-192 source. TLD rods of similar sensitivity (+/- 3%) were placed on a semicircle around the source center which had been precisely localized by either radiographic means or direct measurement. The anisotropy, expressed as a ratio of TLD reading at a given angle relative to the longitudinal source axis, over the reading at 90 degrees, was measured for distances between 1 and 10 cm from the source center. For both media, a marked anisotropy of the high dose rate source was found. In air, there is no detectable variation in anisotropy with distance up to 10 cm from the source. In polystyrene, however, the anisotropy becomes less pronounced with increasing distance due to scatter. For both media, no difference, within the estimated experimental accuracy of +/- 5%, was found between three consecutive sources installed by the vendor.

Air↗

Method for reducing scatter radiation dose to the contralateral breast during tangential breast irradiation therapy.

PURPOSE: To reduce scatter dose to the contralateral breast during tangential breast irradiation therapy. MATERIALS AND METHODS: The authors used a 4-mm-thick commercially available vinyl-coated flexible lead shield that contains a compound of vinyl resin and lead powder of 1-mm-equivalent lead density. Contralateral scatter dose was measured at 5 cm outside the geometric field edge and along the field axis, with and without use of block trays and different wedges. RESULTS: On the skin, contralateral scatter dose from the medial tangential beam was reduced from about 15% to about 5% of the therapeutic dose delivered to the treated breast. The bulk of scatter dose was absorbed within the first 2 cm of breast tissue. CONCLUSION: Reduction in unwanted scatter dose to the contralateral breast is in accord with the philosophy of keeping radiation exposure as low as reasonably achievable and might be of most benefit for young patients.

Breast↗

Craniospinal axis irradiation: an improved electron technique for irradiation of the spinal axis.

In this work we review the dosimetric features of craniospinal axis irradiation in the areas of matching cranial and spinal fields, with reference to the normal structures within the spinal field. The implications of the use of photon or electron modalities for the spinal port were evaluated. A novel method of matching the cranial photon and the spinal electron fields involving a computer-aided junction design is presented. The technique involves moving the photon beam in three steps to degrade its penumbra to match that of the electron field. Thermoluminescent dosimetry in a Rando phantom and computed tomography-based dose-volume histogram study for an illustrative paediatric case were used to compare the dose to normal structures within the spinal field. Our results show that the use of electrons for the spinal field leads to better sparing of deep seated normal structures. In the case of bone marrow, the use of a customized bolus for the spinal field results in an improved dose distribution, making electrons potentially superior to photons for radiobiological reasons.

Bone Marrow↗

Fractionated total body irradiation: some radiobiological considerations.

Fractionated total body irradiation (TBI), as conditioning regimen for bone marrow transplantation in the treatment of non-lymphocytic leukaemia, has proved to be less toxic than single fraction TBI. However, higher relapse rates are reported. The linear quadratic (LQ) model has been applied to calculate equivalent total therapeutic doses as well as equivalent tolerance doses for fractionated TBI. The LQ model predicted that escalating total doses for fractionated TBI will still result in acceptable toxicity to lung while achieving better disease control. There is published clinical data supporting our conclusion from this radiobiological analysis.

Bone Marrow Transplantation↗

Therapeutic gain with hyperfractionation in prophylactic cranial irradiation of children with acute lymphoblastic leukemia.

IQ deterioration after prophylactic cranial irradiation is a dreaded complication for children with acute lymphoblastic leukemia. Alternate treatment schemes are needed that achieve comparable tumor control, but avoid such long-term complication. To this end, a hyperfractionated treatment scheme is proposed. Using two different radiobiological models, we analyze the doses required to achieve equivalent disease control while reducing the severity of late sequelae. Analysis based on the linear-quadratic and surviving fractions models clearly indicates a therapeutic gain with hyperfractionation.

Brain Neoplasms↗

Hyperfractionated, twice-a-day, radiotherapy may decrease IQ deterioration due to prophylactic cranial irradiation in childhood acute lymphoblastic leukemia: a radiobiological analysis.

High cure rates in childhood acute lymphoblastic leukemia (ALL) are being achieved with aggressive systemic chemotherapy and treatment to sanctuary sites including prophylactic cranial irradiation. However, IQ deterioration is a dreaded complication of prophylactic cranial irradiation. IQ deterioration is a late sequela. Since there is evidence--both radiobiological and clinical--to suggest that acute tissue (including tumor) response and late tissue response can be separated by hyper-fractionation, we propose a twice-a-day radiotherapy in prophylactic cranial irradiation of childhood ALL to decrease delayed toxicity. Analysis based on current radiobiological models favors such a treatment scheme. However, only a prospective clinical trial can confirm whether IQ deterioration can be prevented or decreased with hyper-fractionated radiotherapy.

Brain Neoplasms↗

Dosimetry of shaped electron fields using a radial integration method.

The feasibility of an analytical approach to calculate monitor units for shaped electron fields is investigated. A radial integration method is used to calculate the dose at prescription depth from an average output factor and an average depth dose. This concept, as implemented in a commercial planning system, has been tested on various arbitrary fields, and 66 shaped electron fields clinically used for head and neck, chestwall, internal mammary, breast boost, and skin lesions. The measured and prescribed doses agreed within 3.5% or better for 71% of all clinical fields tested; for 91% the agreement was 5.5% or better. The greatest discrepancy (-7.2%) was found for a narrow, long internal mammary field. All treatments were administered on a linear accelerator with electron energies between 6 and 20 MEV.

Electrons↗

Introducing a computerized record and verify system: its impact on the reduction of treatment errors.

A survey of treatment errors has been conducted over a period of several months before and after the introduction of a CMS computerized record and verify system for radiation treatments administered on a Varian CL-1800 accelerator. It was found that treatment errors could be reduced considerably. However, some errors were also caused by wrong data entry into the system. In two instances, errors were detected only through the record and verify system; they had escaped all previous chart checks and would never have been found otherwise. The impact of the computerized record and verify system is analyzed with regard to improved treatment delivery, reception by technologists, and treatment documentation.

Humans↗

Equivalent total doses for different fractionation schemes, based on the linear quadratic model.

A majority of patients receiving radical radiation therapy are treated with 1.8-2.0-Gy fractions, a dose that has evolved from clinical experience. However, other fractionation schemes can be advantageous. When fractionation is altered, the total dose prescribed should lead to equivalent or higher tumor control with the same or less tissue toxicity. To facilitate the use of different fractionation schemes, the authors compiled tables for equivalent biologic doses for late toxicity in normal tissues and tumoricidal doses for epithelial tumors, for various fraction sizes. The linear quadratic model according to Fowler was used. It is shown how these tables should be modified for proliferation of tumors during the course of radiation therapy. The tables make the use of different fractionation schemes easy. They also allow adjustment of total dose if fractionation needs to be changed during the course of treatment.

Cell Survival↗

Monitoring the radiation dose to a multiprogrammable pacemaker during radical radiation therapy: a case report.

Multiprogrammable pacemakers, using complimentary metaloxide semiconductor (CMOS) circuitry, may fail during radiation therapy. We report about a patient who received 6,400 cGy for unresectable carcinoma of the left lung. In supine treatment position, arms raised above the head, the pacemaker was outside the treated area by a margin of at least 1 cm, shielded by cerrobend blocking mounted on a tray. From thermoluminescent dosimeter (TLD) measurements, we estimate that the pacemaker received 620 cGy in scatter doses. Its function was monitored before, during, and after completion of radiation therapy. The pacemaker was functioning normally until the patient's death 5 months after completion of treatment. The relevant electrocardiograms (ECGs) are presented.

Aged↗

Scatter dose from tangential breast irradiation to the uninvolved breast.

Thermoluminescent dosimeters (TLDs) were used to measure scatter radiation to the uninvolved breast in 30 patients who received tangential breast or chest-wall radiation with a technique in which the deep edges of the tangential fields were aligned. In most patients, measurements were made during the 1st week of radiation therapy, after port radiographs were obtained to ensure proper field position and accurate alignment of the posterior tangential field edges. Phantom measurements were made simultaneously with TLD measurements to systematically assess the scatter dose as a function of the wedging, number of fields, type of accelerator, beam energy, and bolus used in each treatment. For most patients, the scatter dose to the contralateral breast at a point on the skin 5 cm outside the edge of the medial beam was 8%-13% of the prescribed dose. However, higher doses (up to 36% of the therapeutic dose) were recorded in some patients.

Breast↗